G1 THERAPEUTICS INC. - COMMON STOCK
4.1300
01-May-24 14:59:59
15 minutes delayed
Stocks
+0.3600
+9.55%
Today's range
3.5200 - 4.2400
ISIN
N/A
Source
NASDAQ
-
22 Feb 2023 09:00:17 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2023 15:46:01 By Nasdaq GlobeNewswire
-
11 Jan 2023 06:00:47 By Nasdaq GlobeNewswire
-
09 Jan 2023 05:30:31 By Nasdaq GlobeNewswire
-
04 Jan 2023 05:30:12 By Nasdaq GlobeNewswire
-
G1 Therapeutics to Participate in the 41st Annual J.P. Morgan Conference
03 Jan 2023 13:00:27 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2022 22:41:26 By Nasdaq GlobeNewswire
-
G1 Therapeutics to Participate in the Virtual Evercore ISI HealthCONx Conference
23 Nov 2022 09:30:26 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Closing of Offering of Common Stock
22 Nov 2022 15:01:04 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
17 Nov 2022 19:12:26 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Proposed Public Offering of Common Stock
17 Nov 2022 15:01:05 By Nasdaq GlobeNewswire
-
G1 Therapeutics Provides Third Quarter 2022 Financial Results and Operational Highlights
02 Nov 2022 05:30:33 By Nasdaq GlobeNewswire
-
02 Nov 2022 05:28:23 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2022 16:40:30 By Nasdaq GlobeNewswire
-
26 Oct 2022 08:26:34 By Nasdaq GlobeNewswire
-
19 Oct 2022 11:30:57 By Nasdaq GlobeNewswire
-
10 Oct 2022 05:30:06 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Oct 2022 16:00:53 By Nasdaq GlobeNewswire